BIONOVATE TECHNOLOGIES CORP

BIONOVATE TECHNOLOGIES CORP

OOTC:BIIO
0.00
USD
+0.00
(-99.00%)
0.00EPS
2.71MMarket Cap

Total Valuation

USD

As of September 30, 2021, BIONOVATE TECHNOLOGIES CORP carries a market capitalization of 2.71M, placing it among publicly traded companies globally. Its enterprise value stands at 2.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.71M
Enterprise Value2.95M

Share Statistics

As of September 30, 2021, BIONOVATE TECHNOLOGIES CORP has 7.75M shares outstanding.

Shares Outstanding7.75M

Valuation Ratios

These figures are as of September 30, 2021.

PB Ratio-5.17
P/TBV Ratio-5.17

Financial Position

As of September 30, 2021, BIONOVATE TECHNOLOGIES CORP maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -45.26, indicating conservative leverage, while an interest coverage ratio of -0.84 demonstrates limited ability to service its debt obligations.

Debt / Equity-45.26
Debt / EBITDA-4.95
Interest Coverage-0.84

Stock Price Statistics

USD

As of the close on November 2, 2026, BIONOVATE TECHNOLOGIES CORP's stock has declined approximately 99.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.04.

52-Week Price Change-99.00%
200-Day Moving Average0.04

Income Statement

USD

Over the twelve months ended September 30, 2021, BIONOVATE TECHNOLOGIES CORP generated - - in revenue and converted that into -105,306.00 in net income, yielding earnings per share of 0.00. EBITDA reached -48,028.00, while operating income came in at -48,028.00.

Operating Income-48,028.00
Pretax Income-105,306.00
Net Income-105,306.00
EBITDA-48,028.00
EBIT-48,028.00

Balance Sheet

USD

As of September 30, 2021, BIONOVATE TECHNOLOGIES CORP holds - - in cash and equivalents against 237,528.00 in total debt, resulting in a net debt position of 237,528.00. Total book value stands at -524,845.00, with working capital of -524,845.00 providing operational flexibility.

Total Debt237,528.00
Net Debt237,528.00
Equity (Book Value)-524,845.00
Book Value Per Share-0.07
Working Capital-524,845.00

Stock Splits

BIONOVATE TECHNOLOGIES CORP's most recent stock split took place on January 10, 2020 with a 100:1 split ratio.

Last Split Date1/10/2020
Split Ratio100:1